The Michigan Engineer News Center

Black biomedical scientists still lag in research funding – here’s why that matters to all Americans

In The Conversation, Omolola Eniola-Adefeso says "If science is to benefit all Americans, science first must be done by all Americans."| Short Read

Written by Omolola Eniola-Adefeso

The statistics tell the story. People of color are more likely to be infected, hospitalized and killed by COVID-19 than white, non-Hispanic people. This grim reality is just one more illustration of an unacceptable truth: Science does not benefit all Americans equally.

While part of the solution lies in making access to health care more equitable, I believe the key to real change is more fundamental. If science is to benefit all Americans, science first must be done by all Americans.

As a Black woman in America and an academic biomedical engineering researcher, I have encountered racial, ethnic and gender discrimination and systemic racism at every stage of my life and career. Through these lived experiences, I have become deeply committed to addressing the “diversity problem” in the academic research enterprise.

This article was originally published in The Conversation. Read the full article.

Portrait of Nicole Casal Moore


Nicole Casal Moore
Media Relations & Research News Director

Michigan Engineering
Communications & Marketing

(734) 647-7087

3214 SI-North

  • Omolola Eniola-Adefeso

    Omolola Eniola-Adefeso

    University Diversity and Social Transformation Professor of Chemical Engineering, Professor of Biomedical Engineering

The outside of the Ford Robotics building

U-Michigan, Ford open world-class robotics complex

The facility will accelerate the future of advanced and more equitable robotics and mobility | Medium Read